Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multi-Site Safety and Effectiveness Study of the Boston Scientific Cardiac Cryoablation System for Drug Refractory, Recurrent Symptomatic Paroxysmal Atrial Fibrillation

NCT06170606 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT06170606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06170606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multi-Site Safety and Effectiveness Study of the Boston Scientific Cardiac Cryoablation System for Drug Refractory, Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
June 28, 2024
Completion date
May 20, 2026
Enrollment
200 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation